Plasmodium species (Malaria)

37,428views

Plasmodium species (Malaria)

CONA CM

CONA CM

Anemia: Clinical
Microcytic anemia: Pathology review
Intrinsic hemolytic normocytic anemia: Pathology review
Extrinsic hemolytic normocytic anemia: Pathology review
Non-hemolytic normocytic anemia: Pathology review
Macrocytic anemia: Pathology review
Myeloproliferative disorders: Pathology review
Myeloproliferative neoplasms: Clinical
Leukemias: Pathology review
Leukemia: Clinical
Lymphoma: Clinical
Plasma cell disorders: Pathology review
Plasma cell disorders: Clinical
Platelet disorders: Pathology review
Thrombocytopenia: Clinical
Bleeding disorders: Clinical
Thrombosis syndromes (hypercoagulability): Pathology review
Thrombophilia: Clinical
Peripheral vascular disease: Clinical
Venous thromboembolism: Clinical
Deep vein thrombosis and pulmonary embolism: Pathology review
Thrombolytics
Antiplatelet medications
Anticoagulants: Warfarin
Anticoagulants: Heparin
Anticoagulants: Direct factor inhibitors
Blood products and transfusion: Clinical
Vaccinations: Clinical
Pneumonia: Clinical
Abscesses
Infective endocarditis: Clinical
Skin and soft tissue infections: Clinical
Septic arthritis
Osteomyelitis
Fever of unknown origin: Clinical
Diarrhea: Clinical
Gastroenteritis
Clostridium difficile (Pseudomembranous colitis)
Urinary tract infections: Clinical
Sexually transmitted infections: Clinical
Meningitis, encephalitis and brain abscesses: Clinical
Clostridium tetani (Tetanus)
Clostridium botulinum (Botulism)
Salmonellosis
Shigella
Vibrio cholerae (Cholera)
Brucella
Mycobacterium tuberculosis (Tuberculosis)
Antituberculosis medications
Mycobacterium leprae
Treponema pallidum (Syphilis)
Leptospira
Upper respiratory tract infection
Pediatric upper airway conditions: Clinical
Pediatric lower airway conditions: Clinical
HIV (AIDS)
Herpes simplex virus
Varicella zoster virus
Herpesvirus medications
Epstein-Barr virus (Infectious mononucleosis)
Cytomegalovirus
Coccidioidomycosis and paracoccidioidomycosis
Aspergillus fumigatus
Mucormycosis
Plasmodium species (Malaria)
Antimalarials
Leishmania
Trypanosoma cruzi (Chagas disease)
Toxoplasma gondii (Toxoplasmosis)
Ascaris lumbricoides
Ancylostoma duodenale and Necator americanus
Strongyloides stercoralis
Enterobius vermicularis (Pinworm)
Anthelmintic medications
Bites and stings: Clinical
Cytomegalovirus infection after transplant (NORD)
Mechanisms of antibiotic resistance
Streptococcus pyogenes (Group A Strep)
Miscellaneous antifungal medications
Candida
Staphylococcus aureus
Pediatric infectious rashes: Clinical
ECG basics
ECG normal sinus rhythm
ECG rate and rhythm
ECG axis
ECG intervals
ECG QRS transition
ECG cardiac hypertrophy and enlargement
ECG cardiac infarction and ischemia
Atrial flutter
Atrial fibrillation
Premature atrial contraction
Atrioventricular nodal reentrant tachycardia (AVNRT)
Wolff-Parkinson-White syndrome
Ventricular tachycardia
Brugada syndrome
Premature ventricular contraction
Long QT syndrome and Torsade de pointes
Ventricular fibrillation
Atrioventricular block
Bundle branch block
Heart blocks: Pathology review
Pulseless electrical activity
Supraventricular arrhythmias: Pathology review
Ventricular arrhythmias: Pathology review
Heart failure
Heart failure: Pathology review
Heart failure: Clinical
Dilated cardiomyopathy
Restrictive cardiomyopathy
Hypertrophic cardiomyopathy
Cardiomyopathies: Clinical
Endocarditis
Myocarditis
Rheumatic heart disease
Tricuspid valve disease
Pulmonary valve disease
Mitral valve disease
Aortic valve disease
Valvular heart disease: Clinical
Pericarditis and pericardial effusion
Cardiac tamponade
Dressler syndrome
Pericardial disease: Clinical
Myocardial infarction
Coronary artery disease: Clinical
Renal artery stenosis
Hypertension: Clinical
Aortic aneurysms and dissections: Clinical
Pulmonary hypertension
Peripheral artery disease
Chronic venous insufficiency
Leg ulcers: Clinical
Congenital heart defects: Clinical
Lymphedema
Syncope: Clinical
Tuberculosis: Pathology review
Asthma: Clinical
Diffuse parenchymal lung disease: Clinical
Bronchiectasis
Obstructive lung diseases: Pathology review
Restrictive lung diseases: Pathology review
Lung cancer: Clinical
Pleural effusion: Clinical
Anatomy clinical correlates: Pleura and lungs
Pleural effusion, pneumothorax, hemothorax and atelectasis: Pathology review
Sleep apnea
Respiratory distress syndrome: Pathology review
Acute respiratory distress syndrome: Clinical
Chronic obstructive pulmonary disease (COPD): Clinical
Pneumothorax: Clinical
Acute kidney injury: Clinical
Chronic kidney disease: Clinical
Nephritic and nephrotic syndromes: Clinical
Hypernatremia: Clinical
Hyponatremia: Clinical
Hyperkalemia: Clinical
Hypokalemia: Clinical
Parathyroid conditions and calcium imbalance: Clinical
Metabolic and respiratory alkalosis: Clinical
Metabolic and respiratory acidosis: Clinical
Kidney stones: Clinical
Esophageal disorders: Clinical
Esophageal surgical conditions: Clinical
Esophagitis: Clinical
Gastroesophageal reflux disease (GERD): Clinical
Peptic ulcers and stomach cancer: Clinical
Malabsorption syndromes: Pathology review
Inflammatory bowel disease: Clinical
Irritable bowel syndrome
Viral hepatitis: Clinical
Jaundice: Clinical
Cirrhosis: Clinical
Pancreatitis: Clinical
Alcohol-associated liver disease
Systemic lupus erythematosus (SLE): Clinical
Antiphospholipid syndrome
Rheumatoid arthritis: Clinical
Joint pain: Clinical
Scleroderma: Pathology review
Sjogren syndrome: Clinical
Seronegative arthritis: Clinical
Vasculitis: Clinical
Inflammatory myopathies: Clinical
Sarcoidosis
Gout and pseudogout: Pathology review
Antigout medications
Fibromyalgia
Hypopituitarism: Clinical
Thyroid nodules and thyroid cancer: Clinical
Hypothyroidism and thyroiditis: Clinical
Hyperthyroidism: Clinical
Adrenal masses and tumors: Clinical
Adrenal insufficiency: Clinical
Congenital adrenal hyperplasia: Clinical
MEN syndromes: Clinical
Cushing syndrome: Clinical
Pituitary adenomas and pituitary hyperfunction: Clinical
Diabetes mellitus: Clinical
Hypercholesterolemia: Clinical
Osteoporosis
Hemochromatosis
Seizures: Clinical
Cerebral vascular disease: Pathology review
Stroke: Clinical
Headaches: Clinical
Dementia and delirium: Clinical
Alzheimer disease
Parkinson disease
Hypokinetic movement disorders: Clinical
Hyperkinetic movement disorders: Clinical
Trigeminal neuralgia
Bell palsy
Multiple sclerosis
Guillain-Barre syndrome
Muscle weakness: Clinical
Myasthenia gravis
Lambert-Eaton myasthenic syndrome
Shock: Clinical
Disorders of consciousness: Clinical
Subarachnoid hemorrhage

Transcript

Watch video only

Malaria is an infection that can be caused by a few different types of Plasmodium species, which are single-celled parasites that get spread around by mosquitoes.

Once the plasmodium gets into the bloodstream, it starts to infect and destroy mainly liver cells and red blood cells, which causes a variety of symptoms and sometimes even death.

Malaria is a serious global health problem that affects millions of people, particularly young children under the age of 5, pregnant women, patients with other health conditions like HIV and AIDS, and travelers who have had no prior exposure to malaria.

Tropical and subtropical regions are hit the hardest, together the most affected regions form the malaria belt, which is a broad band around the equator that includes much of latin america, sub-saharan africa, south asia, and southeast asia.

There are hundreds of types of Plasmodium species, but only five cause malarial disease in humans, and those are Plasmodium falciparum, Plasmodium vivax, Plasmodium malariae, Plasmodium ovale, and Plasmodium knowlesi.

Plasmodium vivax uses a specific erythrocyte surface receptor called the Duffy antigen.

And some individuals, particularly those with sickle-cell anemia lack this receptor, meaning that Plasmodium vivax cannot get into their cells.

In other words, having sickle cell anemia is genetically related to having relative protection from Plasmodium vivax.

Other diseases, like thalassemia and G6PD deficiency make the parasite-infected erythrocyte more susceptible to dying from oxidative stress.

So despite the obvious downside to having any of these diseases, they do offer an upside when it comes to warding off a malaria infection.

In fact, because malaria has historically circulated in Africa, the genes underlying these diseases are thought to have conferred a natural selection advantage and therefore become more common in the genetic pool.

Now, malaria begins when a plasmodium-infected female Anopheles mosquito hunts for a blood meal in the evening and through the night.

Like a tiny flying vampire, the mosquito is drawn to carbon dioxide that get breathed out as well as bodily smells, like foot odor.

At this point, the Plasmodium is in a stage of development called a sporozoite, waiting patiently in the mosquito’s salivary gland.

When the mosquito pierces a person’s skin with its long and needle-shaped tusk, called a proboscis, the tiny, worm-like sporozoites spill out of the mosquito’s saliva and make it into the bloodstream.

Within minutes, the sporozoites reach the liver and mount an attack on hepatic parenchymal cells where they begin asexual reproduction also known as schizogony.

At this point, the plasmodium species vary a bit.

Over the next 1-2 weeks, Plasmodium falciparum, Plasmodium malariae, and Plasmodium knowlesi sporozoites multiply asexually and mature into merozoites, while host hepatic parenchymal cells die.

In contrast, over the next few months to years, Plasmodium vivax and Plasmodium ovale sporozoites enter into a dormant hepatic phase, where they are called hypnozoites.

Hypnozoites don’t divide - instead they snooze for a period of time before entering the process of schizogony, causing a long delay between the initial infection and symptoms from the disease.

This is called the exoerythrocytic phase because it happens outside of the erythrocyte or red blood cell, and it’s generally asymptomatic.

The merozoites are then released into the blood, and each one binds to a surface receptor and invades a red blood cell.

Plasmodium ovale and Plasmodium falciparum invade red blood cells of all ages, whereas Plasmodium vivax prefers to invade reticulocytes which are young, immature red blood cells, and Plasmodium malariae and Plasmodium knowlesi prefer to invade older red blood cells.

Once inside the red blood cell, the merozoite undergoes asexual reproduction and a series of transformational changes.

This phase is known as the erythrocytic phase of malaria, because it happens inside of the red blood cell and generally lasts 2 to 3 days.

In the first stage of the erythrocytic phase the merozoite looks like a tiny ring within the red blood cell and is called an early trophozoite or a ring form.

In the second stage, the ring form trophozoite grows and is referred to as a late trophozoite.

In the third and final stage, the parasite grows some more by digesting hemoglobin and leaves behind hemozoin, which under a microscope looks a little like a brown feces smudge on the red blood cell, and at this point the parasite is called a schizont.

This is the actual replicative phase in which the parasite undergoes mitosis and differentiates into lots of merozoites which can get released into the blood.

Now, instead of going into the erythrocytic phase again, some of the merozoites undergo gametogony which is where they divide and give rise to gametocytes which are little sausage-shaped sexual forms that can be either male or female.

These gametocytes remain inside of a red blood cell, and can get sucked up by another female Anopheles mosquito that might take a blood meal from the infected person.

The gametocytes can then reach the mosquito's gut where they mature a bit more and then fuse together to form a zygote.

This part of the plasmodium life cycle is called sporogony, and it’s sexual reproduction, as opposed to the schizogony or asexual reproduction that happened in the liver and red blood cells.

The zygote then goes on to develop further, it becomes an ookinete and then an oocyst that ruptures in the mosquito’s gut, releasing thousands of sporozoites which navigate their way into the mosquito's salivary gland, in order to repeat the cycle all over again.

Now, the incubation time, which is the period of time between infection and symptom onset, varies depending on the plasmodium species.

Plasmodium falciparum incubates for a few days, whereas Plasmodium malariae incubates for a few weeks.

The release of tumor necrosis factor alpha and other inflammatory cytokines, causes fevers that typically occur in paroxysms or short bursts, and correspond to the rupture of the infected red blood cells, which happens in waves of reproductive cycles unique for each plasmodium species.

For Plasmodium malariae, fevers happen every 72 hours, and is called quartan fever.

For Plasmodium vivax and Plasmodium ovale, fevers happen every 48 hours, and these are called tertian fever.

For Plasmodium knowlesi, the fever happens every 24 hours, and for Plasmodium falciparum, the pattern can vary - sometimes following the pattern of tertian fever, while other times the fevers happen daily, earning it the name malignant tertian fever.

Key Takeaways

Plasmodium is a genus of parasites that cause malaria in humans and other animals. Five species of Plasmodium primarily infect humans: P. falciparum, P. vivax, P. ovale, P. malariae, and P. knowlesi. People get infected with malaria when they are bitten by a plasmodium-infected female Anopheles mosquito. P. falciparum is known to cause the most dangerous form of malaria, resulting in most of malaria deaths worldwide. Treatment typically involves antimalarial drugs such as chloroquine, mefloquine, or artemisinin-based combination therapies.